Quick Listen: Scrip's Five Must-Know Things
Executive Summary
In this week's podcast edition of Five Must-Know Things: CAR-Ts move into earlier treatment; Sanofi bets big on super antibodies; takeaways from the world’s largest dermatology conference; China moves towards imported COVID vaccines; and R&D experts discuss the superbug threat.
Join us for an audio catch-up on the major events in the biopharma industry over the past business week, as reported by Scrip's global team, in this podcast version of Five Must-Know Things.
This episode covers insights for the business week ended 1 April 2022, including: CAR-Ts move into earlier treatment; Sanofi bets big on super antibodies; takeaways from the world’s largest dermatology conference; China moves towards imported COVID vaccines; and R&D experts discuss the superbug threat.
This and all our other podcasts are available on the Informa Pharma Intelligence channel on Apple Podcasts, Google Podcasts, SoundCloud, TuneIn and Spotify Podcasts, and via smart speakers if one of these platforms has been set up as your default podcast provider.
Stories mentioned in this episode:
(Also see "As CAR-T Therapies Move Into Earlier Lines, Best Uses Begin To Come Into Focus" - Scrip, 25 Mar, 2022.)
(Also see "Sanofi Bets Big On IgM ‘Super Antibodies’ In Potential $6bn Cancer and Immunology Deal" - Scrip, 29 Mar, 2022.)
(Also see "Top Five Takeaways From World's Largest Dermatology Conference" - Scrip, 29 Mar, 2022.)
(Also see "Facing COVID Surge, China Revises Course To Support Imported mRNA Vaccines" - Scrip, 31 Mar, 2022.)
(Also see "Global R&D Heads Talk Superbugs, PROTACs And More" - Scrip, 29 Mar, 2022.)